Relapsing Remitting MS
Links shared publicly online about this topic
Laquinimod Reduces Relapse Rate in Relapsing-Remitting MS --Doctors Lounge
doctorslounge.com — “Laquinimod Reduces Relapse Rate in Relapsing-Remitting MS --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on March 15, 2012 at 2:37 am By:
Laquinimod Reduces Relapse Rate in Relapsing-Remitting MS http://t.co/P7yOfY2C #Health #Medicine
MS Trial Alert: Trial of Vitamin D Supplementation Recruiting People with Relapsing-Remitting MS : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on April 19, 2012 at 3:12 pm By:
News! MS Trial Alert: Trial of Vitamin D Supplementation Recruiting People with Relapsing-Remitting MS http://t.co/NkXlzX9r
Merck Seeks European License For Cladribine for relapsing remitting MS
medicalnewstoday.com — “Merck Serono announced that it is seeking a European license for cladribine, its oral therapy that is in late-stage clinical trials for relapsing remitting MS. The announcement comes aft” View full resource at medicalnewstoday.com
Most Recently Shared on July 27, 2009 at 11:32 am By:
MedNewsToday: Merck Seeks European License For Cladribine for relapsing remitting MS: Merck Serono .. http://bit.ly/NUQkf
First Oral Treatment For Highly Active Relapsing Remitting Multiple Sclerosis Provides New Choice For UK Patients Failing On Injections
medicalnewstoday.com — “The first oral treatment for multiple sclerosis (MS) has been given the green light by UK regulators and is now available in the UK. Fingolimod0.5 mg (Gilenya™) has been authorised for peopl” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2011 at 2:59 pm By:
First Oral Treatment For Highly Active Relapsing Remitting Multiple Sclerosis Provides New Choice For UK Patient... http://bit.ly/gBGjj9
Managing Relapses and the Progression of MS
healthline.com — “One of the challenges of multiple sclerosis is coping with the constantly changing state of the disease. Learn about MS progression and dealing with relapses.” View full resource at healthline.com
Most Recently Shared on March 25, 2012 at 8:03 pm By:
One of the biggest challenges of living with multiple sclerosis is coping with the changing state of the disease. http://t.co/NJYz6fOZ
Dimethyl Fumarate Considerably Reduces MS Relapses And Disability Progression
medicalnewstoday.com — “240 mg of Dimethyl Fumarate (BG-12) taken orally two or three times a day showed reduced relapses by about half in patients with relapsing-remitting multiple sclerosis (PRMS) compared to those on” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2011 at 8:05 pm By:
Dimethyl Fumarate Considerably Reduces MS Relapses And Disability Progression http://t.co/7Xlw5TiI #multiplesclerosis
EMD Serono receives FDA CRL on Cladribine Tablets NDA for relapsing-remitting multiple sclerosis
news-medical.net — “EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).” View full resource at news-medical.net
Most Recently Shared on March 2, 2011 at 10:55 am By:
News-Medical.Net Health News and Oncology
Oncology News: EMD Serono receives FDA CRL on Cladribine Tablets NDA for relapsing-remitting multiple sclerosis:... http://bit.ly/eokKUi
Neurology Medical News about Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting
mdlinx.com — “A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing"remitting multiple sclerosis (TIME MS)” View full resource at mdlinx.com
Most Recently Shared on January 5, 2010 at 9:54 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro: A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combin http://url4.eu/13ckw
Neurology Article | Multiple Sclerosis, Relapsing-Remitting
mdlinx.com — “Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis” View full resource at mdlinx.com
Most Recently Shared on August 10, 2011 at 3:28 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis: Multiple S... http://bit.ly/qv0LaM #neuro
Psychiatry Article | Multiple Sclerosis, Relapsing-Remitting
mdlinx.com — “Quality of life, depression and fatigue in mildly disabled patients with relapsing--remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (Cognitive Impairment in Multiple Sclerosis) study” View full resource at mdlinx.com
Most Recently Shared on April 20, 2011 at 11:12 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple scler... http://bit.ly/h9VUh5 #PSY
Neurology Medical News about Multiple Sclerosis, Relapsing-Remitting; Daclizumab
mdlinx.com — “Daclizumab for relapsing remitting multiple sclerosis” View full resource at mdlinx.com
Most Recently Shared on June 18, 2010 at 9:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Daclizumab for relapsing remitting multiple sclerosis: Cochrane Reviews http://bit.ly/duoO5g #neurology #mdlinx
Medical Student Article | Multiple Sclerosis, Relapsing-Remitting
mdlinx.com — “Impact of exposure to interferon beta-1a on outcomes in patients with relapsing--remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study” View full resource at mdlinx.com
Most Recently Shared on January 14, 2011 at 5:52 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dr Victor Rivera. just commented on: Impact of exposure to interferon beta-1a on outcomes in patient... http://bit.ly/fbnRBk #authorcmnt
ALLOZYNE Announces Completion Of Phase IA Trial By AZ01, A Long Lasting Interferon For Treatment Of Relapsing Remitting Multiple Sclerosis
medicalnewstoday.com — “ALLOZYNE, Inc. announced, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatme” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 2:05 pm By:
ALLOZYNE Announces Completion Of Phase IA Trial By AZ01, A Long Lasting Interferon ? For Treatment Of Relapsing Remit... http://mnt.to/3PWJ
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing Remitting MS
medicalnewstoday.com — “An advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form” View full resource at medicalnewstoday.com
Most Recently Shared on August 7, 2010 at 2:05 pm By:
MNT Pharma News Health News and Pharma
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing... http://mnt.to/3H7B
Protagen To Apply UNIarray Platform For Biogen Idec To Help Discover Biomarkers In Relapsing Remitting Multiple Sclerosis
medicalnewstoday.com — “Protagen AG, a specialist in in-vitro diagnostics and GMP-compliant protein analysis announced today that they will be using the UNIarray® Platform to help discover biomarkers in relapsing rem” View full resource at medicalnewstoday.com
Most Recently Shared on March 29, 2011 at 9:05 am By:
Protagen To Apply UNIarray Platform For Biogen Idec To Help Discover Biomarkers In Relapsing Remitting Multiple Sclerosis http://mnt.to/3SQy
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Doctors Lounge
DoctorsLounge medical community, news, discussions and blogs.
-
National MS Society
Multiple sclerosis stops people from moving. We exist to make sure it doesn't.
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
Advertisement
